Soleno Therapeutics (SLNO) Preferred Dividend Payments (2016)
Soleno Therapeutics (SLNO) reported Preferred Dividend Payments of $172.0 for Q4 2016, down 100.0% quarter-over-quarter from $3.7 million in Q3 2016.
Soleno Therapeutics (SLNO) Preferred Dividend Payments (2016) Analysis & Trends
Soleno Therapeutics (SLNO) has 1 years of Preferred Dividend Payments data on file, last reported at $172.0 in Q4 2016.
- Preferred Dividend Payments for Q4 2016 came in at $172.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2016 was $3.7 million (changed N/A YoY), and the FY2016 annual result was $3.7 million, changed N/A from the prior year.
- Preferred Dividend Payments declined to $172.0 in Q4 2016 per SLNO's latest filing, from $3.7 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $3.7 million in Q3 2016 and troughed at $172.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 172.00 |
| Sep 30, 2016 | 3.65 Mn |